Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
JAPAN: +81-50-5539-1737
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Liver Cancer Therapeutics Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026

  • Purchase Options

 

Summary

The global Liver Cancer Therapeutics Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

The Liver Cancer Therapeutics Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Liver Cancer Therapeutics Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • ArQule
  • Bayer
  • Bristol-Myers Squibb
  • Celsion
  • Eisai
  • Exelixis
  • Roche
  • Merck
  • Pfizer
  • IntegraGen

By the Product Type, the market is primarily segmented into:

  • Targeted Therapy
  • Radiation Therapy
  • Immunotherapy
  • Chemotherapy
  • Other

By Applications, the market is segmented into:

  • Hepatocellular Carcinoma
  • Cholangio Carcinoma
  • Hepatoblastoma
  • Other

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Liver Cancer Therapeutics Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Liver Cancer Therapeutics Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Liver Cancer Therapeutics Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Liver Cancer Therapeutics Market

The Liver Cancer Therapeutics Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Liver Cancer Therapeutics Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Liver Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Targeted Therapy
1.4.3 Radiation Therapy
1.4.4 Immunotherapy
1.4.5 Chemotherapy
1.4.6 Other
1.5 Market by Application
1.5.1 Global Liver Cancer Therapeutics Market Share by Application (2019-2025)
1.5.2 Hepatocellular Carcinoma
1.5.3 Cholangio Carcinoma
1.5.4 Hepatoblastoma
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Liver Cancer Therapeutics Market Size
2.2 Liver Cancer Therapeutics Growth Trends by Regions
2.2.1 Liver Cancer Therapeutics Market Size by Regions (2019-2025)
2.2.2 Liver Cancer Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis

3 Market Share by Key Players
3.1 Liver Cancer Therapeutics Market Size by by Players
3.1.1 Global Liver Cancer Therapeutics Revenue by by Players (2014-2019)
3.1.2 Global Liver Cancer Therapeutics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Liver Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Liver Cancer Therapeutics Key Players Head office and Area Served
3.3 Key Players Liver Cancer Therapeutics Product/Solution/Service
3.4 Date of Enter into Liver Cancer Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Liver Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Liver Cancer Therapeutics Market Size by Application (2014-2019)

5 North America
5.1 North America Liver Cancer Therapeutics Market Size (2014-2019)
5.2 Liver Cancer Therapeutics Key Players in North America
5.3 North America Liver Cancer Therapeutics Market Size by Type
5.4 North America Liver Cancer Therapeutics Market Size by Application

6 Europe
6.1 Europe Liver Cancer Therapeutics Market Size (2014-2019)
6.2 Liver Cancer Therapeutics Key Players in Europe
6.3 Europe Liver Cancer Therapeutics Market Size by Type
6.4 Europe Liver Cancer Therapeutics Market Size by Application

7 China
7.1 China Liver Cancer Therapeutics Market Size (2014-2019)
7.2 Liver Cancer Therapeutics Key Players in China
7.3 China Liver Cancer Therapeutics Market Size by Type
7.4 China Liver Cancer Therapeutics Market Size by Application

8 Japan
8.1 Japan Liver Cancer Therapeutics Market Size (2014-2019)
8.2 Liver Cancer Therapeutics Key Players in Japan
8.3 Japan Liver Cancer Therapeutics Market Size by Type
8.4 Japan Liver Cancer Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Liver Cancer Therapeutics Market Size (2014-2019)
9.2 Liver Cancer Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Liver Cancer Therapeutics Market Size by Type
9.4 Southeast Asia Liver Cancer Therapeutics Market Size by Application

10 India
10.1 India Liver Cancer Therapeutics Market Size (2014-2019)
10.2 Liver Cancer Therapeutics Key Players in India
10.3 India Liver Cancer Therapeutics Market Size by Type
10.4 India Liver Cancer Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Liver Cancer Therapeutics Market Size (2014-2019)
11.2 Liver Cancer Therapeutics Key Players in Central & South America
11.3 Central & South America Liver Cancer Therapeutics Market Size by Type
11.4 Central & South America Liver Cancer Therapeutics Market Size by Application

12 International Players Profiles
12.1 ArQule
12.1.1 ArQule Company Details
12.1.2 Company Description and Business Overview
12.1.3 Liver Cancer Therapeutics Introduction
12.1.4 ArQule Revenue in Liver Cancer Therapeutics Business (2014-2019))
12.1.5 ArQule Recent Development
12.2 Bayer
12.2.1 Bayer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Liver Cancer Therapeutics Introduction
12.2.4 Bayer Revenue in Liver Cancer Therapeutics Business (2014-2019)
12.2.5 Bayer Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Liver Cancer Therapeutics Introduction
12.3.4 Bristol-Myers Squibb Revenue in Liver Cancer Therapeutics Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Celsion
12.4.1 Celsion Company Details
12.4.2 Company Description and Business Overview
12.4.3 Liver Cancer Therapeutics Introduction
12.4.4 Celsion Revenue in Liver Cancer Therapeutics Business (2014-2019)
12.4.5 Celsion Recent Development
12.5 Eisai
12.5.1 Eisai Company Details
12.5.2 Company Description and Business Overview
12.5.3 Liver Cancer Therapeutics Introduction
12.5.4 Eisai Revenue in Liver Cancer Therapeutics Business (2014-2019)
12.5.5 Eisai Recent Development
12.6 Exelixis
12.6.1 Exelixis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Liver Cancer Therapeutics Introduction
12.6.4 Exelixis Revenue in Liver Cancer Therapeutics Business (2014-2019)
12.6.5 Exelixis Recent Development
12.7 Roche
12.7.1 Roche Company Details
12.7.2 Company Description and Business Overview
12.7.3 Liver Cancer Therapeutics Introduction
12.7.4 Roche Revenue in Liver Cancer Therapeutics Business (2014-2019)
12.7.5 Roche Recent Development
12.8 Merck
12.8.1 Merck Company Details
12.8.2 Company Description and Business Overview
12.8.3 Liver Cancer Therapeutics Introduction
12.8.4 Merck Revenue in Liver Cancer Therapeutics Business (2014-2019)
12.8.5 Merck Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Liver Cancer Therapeutics Introduction
12.9.4 Pfizer Revenue in Liver Cancer Therapeutics Business (2014-2019)
12.9.5 Pfizer Recent Development
12.10 IntegraGen
12.10.1 IntegraGen Company Details
12.10.2 Company Description and Business Overview
12.10.3 Liver Cancer Therapeutics Introduction
12.10.4 IntegraGen Revenue in Liver Cancer Therapeutics Business (2014-2019)
12.10.5 IntegraGen Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Table
List of Tables and Figures

Table Liver Cancer Therapeutics Key Market Segments
Table Key Players Liver Cancer Therapeutics Covered
Table Global Liver Cancer Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Targeted Therapy Figures
Table Key Players of Targeted Therapy
Figuer Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figuer Immunotherapy Figures
Table Key Players of Immunotherapy
Figuer Chemotherapy Figures
Table Key Players of Chemotherapy
Figuer Other Figures
Table Key Players of Other
Table Global Liver Cancer Therapeutics Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Liver Cancer Therapeutics Market Share by Application in 2018 & 2025
Figure Hepatocellular Carcinoma Case Studies
Figure Cholangio Carcinoma Case Studies
Figure Hepatoblastoma Case Studies
Figure Other Case Studies
Figure Liver Cancer Therapeutics Report Years Considered
Figure Global Liver Cancer Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Liver Cancer Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Liver Cancer Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Liver Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Liver Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Liver Cancer Therapeutics Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Liver Cancer Therapeutics Revenue by by Players (2014-2019) (Million US$)
Table Global Liver Cancer Therapeutics Market Share by by Players (2014-2019)
Figure Global Liver Cancer Therapeutics Market Share by by Players in 2018
Table Global Liver Cancer Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Liver Cancer Therapeutics Product/Solution/Service
Table Date of Enter into Liver Cancer Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Liver Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Liver Cancer Therapeutics Market Size Share by Type (2014-2019)
Figure Global Liver Cancer Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Liver Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Liver Cancer Therapeutics Market Size Share by Application (2014-2019)
Figure Global Liver Cancer Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Liver Cancer Therapeutics Revenue Market Share by Application in 2018
Figure North America Liver Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table North America Key Players Liver Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table North America Key Players Liver Cancer Therapeutics Market Share (2018-2019)
Table North America Liver Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table North America Liver Cancer Therapeutics Market Share by Type 2014-2019
Table North America Liver Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table North America Liver Cancer Therapeutics Market Share by Application 2014-2019
Figure Europe Liver Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Liver Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Liver Cancer Therapeutics Market Share (2018-2019)
Table Europe Liver Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Europe Liver Cancer Therapeutics Market Share by Type 2014-2019
Table Europe Liver Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Europe Liver Cancer Therapeutics Market Share by Application 2014-2019
Figure China Liver Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Liver Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Liver Cancer Therapeutics Market Share (2018-2019)
Table China Liver Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table China Liver Cancer Therapeutics Market Share by Type 2014-2019
Table China Liver Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table China Liver Cancer Therapeutics Market Share by Application 2014-2019
Figure Japan Liver Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Liver Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Liver Cancer Therapeutics Market Share (2018-2019)
Table Japan Liver Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Japan Liver Cancer Therapeutics Market Share by Type 2014-2019
Table Japan Liver Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Japan Liver Cancer Therapeutics Market Share by Application 2014-2019
Figure Southeast Asia Liver Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Liver Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Liver Cancer Therapeutics Market Share (2018-2019)
Table Southeast Asia Liver Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Liver Cancer Therapeutics Market Share by Type 2014-2019
Table Southeast Asia Liver Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Liver Cancer Therapeutics Market Share by Application 2014-2019
Figure India Liver Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Liver Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Liver Cancer Therapeutics Market Share (2018-2019)
Table India Liver Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table India Liver Cancer Therapeutics Market Share by Type 2014-2019
Table India Liver Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table India Liver Cancer Therapeutics Market Share by Application 2014-2019
Figure Central & South America Liver Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Liver Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Liver Cancer Therapeutics Market Share (2018-2019)
Table Central & South America Liver Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Central & South America Liver Cancer Therapeutics Market Share by Type 2014-2019
Table Central & South America Liver Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Central & South America Liver Cancer Therapeutics Market Share by Application 2014-2019
Table ArQule Company Details
Table ArQule Revenue in Liver Cancer Therapeutics Business 2014-2019 (Million US$)
Figure ArQule Revenue Growth Rate in Liver Cancer Therapeutics Business (2014-2019)
Table ArQule Recent Development
Table Bayer Company Details
Table Bayer Revenue in Liver Cancer Therapeutics Business 2014-2019 (Million US$)
Figure Bayer Revenue Growth Rate in Liver Cancer Therapeutics Business (2014-2019)
Table Bayer Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Liver Cancer Therapeutics Business 2014-2019 (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Liver Cancer Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Celsion Company Details
Table Celsion Revenue in Liver Cancer Therapeutics Business 2014-2019 (Million US$)
Figure Celsion Revenue Growth Rate in Liver Cancer Therapeutics Business (2014-2019)
Table Celsion Recent Development
Table Eisai Company Details
Table Eisai Revenue in Liver Cancer Therapeutics Business 2014-2019 (Million US$)
Figure Eisai Revenue Growth Rate in Liver Cancer Therapeutics Business (2014-2019)
Table Eisai Recent Development
Table Exelixis Company Details
Table Exelixis Revenue in Liver Cancer Therapeutics Business 2014-2019 (Million US$)
Figure Exelixis Revenue Growth Rate in Liver Cancer Therapeutics Business (2014-2019)
Table Exelixis Recent Development
Table Roche Company Details
Table Roche Revenue in Liver Cancer Therapeutics Business 2014-2019 (Million US$)
Figure Roche Revenue Growth Rate in Liver Cancer Therapeutics Business (2014-2019)
Table Roche Recent Development
Table Merck Company Details
Table Merck Revenue in Liver Cancer Therapeutics Business 2014-2019 (Million US$)
Figure Merck Revenue Growth Rate in Liver Cancer Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Liver Cancer Therapeutics Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Liver Cancer Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table IntegraGen Company Details
Table IntegraGen Revenue in Liver Cancer Therapeutics Business 2014-2019 (Million US$)
Figure IntegraGen Revenue Growth Rate in Liver Cancer Therapeutics Business (2014-2019)
Table IntegraGen Recent Development
Table Global Liver Cancer Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Liver Cancer Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Liver Cancer Therapeutics Market Size Share by Regions in 2025
Figure North America Liver Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Liver Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Liver Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Liver Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Liver Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Liver Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Liver Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Liver Cancer Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Liver Cancer Therapeutics Market Size by Product (2019-2025)
Figure Global Liver Cancer Therapeutics Market Size by Product in 2025
Table Global Liver Cancer Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Liver Cancer Therapeutics Market Size by Application (2019-2025)
Figure Global Liver Cancer Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us